Biogen Jumps on Gene Therapy Train with Nightstar Acquisition

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 3 (Table of Contents)

Published: 12 Mar-2019

DOI: 10.3833/pdr.v2019.i3.2411     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

In a move to rebuild its ophthalmology pipeline, Biogen has acquired gene therapy specialist, Nightstar Therapeutics, for approximately US$800 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details